B. Riley Securities, Inc. Journey Medical Corp Call Options Transaction History
B. Riley Securities, Inc.
- $460 Billion
- Q4 2022
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding DERM
# of Institutions
36Shares Held
2.68MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA310KShares$1.62 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny271KShares$1.41 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA223KShares$1.16 Million0.0% of portfolio
-
American Financial Group Inc180KShares$937,8000.25% of portfolio
-
Tang Capital Management LLC San Diego, CA139KShares$722,2360.06% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $60.4M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...